Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 6Breast Neoplasms 6Endometrial Neoplasms 4Fallopian Tube Neoplasms 3Carcinoma, Ovarian Epithelial 3Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Neoplasms by Site 1Mesothelioma 1Lymphoma 1Leukemia 1Hereditary Sensory and Autonomic Neuropathies 1Hematologic Neoplasms 1Head and Neck Neoplasms 1ER+ HER2- Advanced Breast Cancer 1Digestive System Neoplasms 1Carcinosarcoma 1Breast Diseases 1Adenocarcinoma Of Esophagus 1

Interventions

ribociclib 1palbociclib 1olaparib 1alectinib 1Paclitaxel 1Fulvestrant 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Digestive System Neoplasms × ribociclib × Gynecologic × Clear all
NCT05238922 2026-04-14

Study of INCB123667 in Subjects With Advanced Solid Tumors

Incyte Corporation

Phase 1 Recruiting
604 enrolled
BreastGastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡